BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3304705)

  • 1. Nitrate tolerance: the lack of effect of N-acetylcysteine.
    Parker JO; Farrell B; Lahey KA; Rose BF
    Circulation; 1987 Sep; 76(3):572-6. PubMed ID: 3304705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive administration of intravenous N-acetylcysteine and development of tolerance to isosorbide dinitrate in patients with angina pectoris.
    Boesgaard S; Aldershvile J; Poulsen HE
    Circulation; 1992 Jan; 85(1):143-9. PubMed ID: 1728443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous oral N-acetylcysteine treatment and development of nitrate tolerance in patients with stable angina pectoris.
    Boesgaard S; Aldershvile J; Pedersen F; Pietersen A; Madsen JK; Grande P
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):889-93. PubMed ID: 1714011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short and long-acting oral nitrates for stable angina pectoris.
    Thadani U; Lipicky RJ
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):611-23. PubMed ID: 7848896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.
    Parker JO; VanKoughnett KA; Fung HL
    Am J Cardiol; 1984 Jul; 54(1):8-13. PubMed ID: 6430057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrate tolerance.
    Parker JO
    Am J Cardiol; 1985 Dec; 56(17):28I-31I. PubMed ID: 3934952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris.
    Parker JO; Vankoughnett KA; Farrell B
    Am J Cardiol; 1985 Nov; 56(12):724-8. PubMed ID: 3933317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolerance to a sustained release form of isosorbide dinitrate: comparison between 20 mg four times and 40 mg twice-daily administrations].
    Hiasa Y; Hamai K; Wada T; Ootani R; Shinohara H; Aihara T; Bando M; Nakai Y; Kataoka Y
    Kokyu To Junkan; 1991 Sep; 39(9):925-30. PubMed ID: 1749871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic and anti-angina effects of transdermal nitroglycerin after acute and chronic administration. Additive effect of sublingual isosorbide dinitrate].
    Scardi S; Pandullo C; Pivotti F; Ceschia G; Pollavini G
    G Ital Cardiol; 1986 Nov; 16(11):895-903. PubMed ID: 3104123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrate tolerance.
    Parker JO
    Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine modifies the acute effects of isosorbide-5-mononitrate in angina pectoris patients evaluated by exercise testing.
    Svendsen JH; Klarlund K; Aldershvile J; Waldorff S
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):320-3. PubMed ID: 2468964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrate tolerance. A problem during continuous nitrate administration.
    Parker JO
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S21-5. PubMed ID: 2113001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrate tolerance: influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin.
    Dalal JJ; Yao L; Parker JO
    J Am Coll Cardiol; 1983 Jul; 2(1):115-20. PubMed ID: 6406586
    [No Abstract]   [Full Text] [Related]  

  • 17. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
    Kośmicki M; Sadowski Z; Szwed H; Kowalik I
    Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate.
    Bassan MM
    J Am Coll Cardiol; 1990 Oct; 16(4):936-40. PubMed ID: 2212374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development and reversal of tolerance to antianginal effect of isosorbide dinitrate in patients with effort angina.
    Toyosaki N; Katsuki T; Fujii M; Kawada Y; Komaba A; Watabiki H; Hasegawa H; Suzuki S; Natsume T; Yaginuma T
    Jpn Circ J; 1989 May; 53(5):395-405. PubMed ID: 2769927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy.
    Dalal JJ; Parker JO
    Am J Cardiol; 1984 Aug; 54(3):286-8. PubMed ID: 6431795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.